Brand Post

Genomics Services Market Projected to Surpass USD 25.18 Billion by 2035; Increasing Genetic Disorders’ Prevalence is Driving Market Growth Globally – SNS Insider

By Globenewswire March 5, 2026 • 5:36 pm

Expanding Pharmaceutical R&D Investment, Government-Funded Genomics Programs, and Rapid Adoption of NGS-Based Diagnostics Accelerate Global Genomics Services Market Growth.

Austin, United States, March 05, 2026 (GLOBE NEWSWIRE) — Genomics Services Market Size & Growth Analysis:

As per SNS Insider Research, The Genomics Services Market size was valued at USD 7.94 billion in 2025 and is expected to reach USD 25.18 billion by 2035, growing at a CAGR of 11.8% over 2026-2035. The growth of the market is driven by increasing prevalence of genetic disorders, government funding for precision medicine initiatives, and rising adoption of genomic data in clinical diagnostics and pharmaceutical research.

Market Size and Forecast:

  • Market Size in 2025: USD 7.94 billion
  • Market Size by 2035: USD 25.18 billion
  • CAGR: 11.8% from 2026 to 2035
  • Base Year: 2025
  • Forecast Period: 2026–2035
  • Historical Data: 2022–2024

Genomics Services Market

Get a Sample Report of Genomics Services Market: https://www.snsinsider.com/sample-request/2873

The U.S. Genomics Services Market size was worth USD 3.18 billion in 2025 and is expected to reach USD 10.04 billion by 2035, growing at a CAGR of 12.1% from 2026-2035. Government investment in precision medicine, moderately high levels of insurance reimbursement for molecular diagnostics, and increased pharmaceutical and biotech spending on genomic research and companion diagnostics help to drive market growth in the U.S.

Rising Adoption of Precision Medicine and Companion Diagnostics is Boosting Market Growth Globally

The adoption of liquid biopsy testing, circulating tumor DNA monitoring, and minimal residual disease detection for improved treatment response assessment and early relapse identification are the main factors driving the growth of the digital PCR market share due to rising cancer prevalence and precision oncology demand. The market’s foundation, clinical and research market penetration, and total market share are all being fueled by these customized cancer management and targeted therapy selection options.

Major Players Listed in this Report:

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • Labcorp
  • Quest Diagnostics Incorporated
  • BGI Genomics Co., Ltd.
  • Eurofins Scientific SE
  • Novogene Corporation
  • Pacific Biosciences of California, Inc.
  • Oxford Nanopore Technologies plc
  • Agilent Technologies, Inc.
  • GENEWIZ
  • CD Genomics
  • Psomagen, Inc.
  • Macrogen Inc.
  • Strand Life Sciences
  • Dante Labs
  • Fulgent Genetics, Inc.
  • Baylor Genetics
  • Ambry Genetics
  • InVitae Corporation

Segmentation Analysis:

By Services Type

The next-generation sequencing segment accounted for the highest revenue share of approximately 38.42% in 2025, owing to its widespread adoption across oncology diagnostics, rare disease research, and infectious disease surveillance applications globally. The epigenomics services segment is anticipated to achieve the highest CAGR of nearly 13.27% during the 2026–2035 period, driven by the increasing demand from cancer epigenetics research and aging biology studies globally.

By Technology

By 2025, the next-generation sequencing technology segment contributed the largest revenue share of 44.18% due to its scalability across whole genome. The polymerase chain reaction (PCR) segment maintains a significant and stable market presence due to its established role in clinical diagnostics, infectious disease testing, and genotyping validation.

By Application

The diagnostics segment accounted for the largest share of the genomic services market with about 52.36%, owing to the direct clinical utility of genomic testing in cancer diagnosis, inherited disease screening. The research segment is slated to grow at the fastest rate throughout the forecast period of 2026–2035, as academic research institutes, pharmaceutical companies.

By End-User

Pharmaceutical and biotechnological companies accounted for the leading end-user share of the genomic services market in 2025, owing to their extensive reliance on genomic services for drug discovery globally. In addition, contract research organizations (CROs) are slated to grow at the fastest rate throughout the forecast period of 2026–2035, as sponsors increasingly outsource genomic testing workflows to specialized CROs with established sequencing infrastructure.

Need Any Customization Research on Genomics Services Market, Enquire Now: https://www.snsinsider.com/enquiry/2873

Genomics Services Market Segmentation

By Services Type

  • Gene Expression Services (RNASeq)
  • Epigenomics Services
  • Genotyping
  • Next-Generation Sequencing
  • Others

By Technology

  • Polymerase Chain Reaction (PCR)
  • Next-Generation Sequencing (NGS)
  • Microarray
  • Others

By Application

  • Diagnostics
  • Research
  • Others

By End-User

  • Research Institutes
  • Healthcare Facilities & Diagnostic Centers
  • Pharmaceutical & Biotechnological Companies
  • Contract Research Organizations (CROs)

Regional Insights:

Asia Pacific is the fastest-growing segment in the genomic services market with a CAGR of 13.84%, as the awareness about precision medicine, government-funded genomics programs, and healthcare infrastructure modernization in countries, such as China, India, Japan, and South Korea is growing.

North America held the largest revenue share of over 40.12% in 2025 of the genomic services market due to an established genomics research ecosystem, high concentration of pharmaceutical and biotechnology companies.

Recent Developments:

  • In February 2025, Illumina, Inc. (est. 1998) expanded its genomic services capabilities with enhanced whole genome sequencing and multi-omics service packages for pharmaceutical and biotech clients, aiming to accelerate drug discovery workflows and companion diagnostic co-development across its global service laboratory network.
  • In May 2024, Thermo Fisher Scientific Inc. (est. 1956) launched an enhanced Ion Torrent-based targeted sequencing service panel for oncology biomarker profiling and companion diagnostic development, deployed across CRO and pharmaceutical client networks to improve clinical trial genomic data quality and turnaround speed.

Exclusive Sections of the Report (The USPs):

  • TECHNOLOGY PLATFORM & SEQUENCING PERFORMANCE METRICS – helps you evaluate sequencing throughput capacity, turnaround time benchmarks, adoption of next-generation and third-generation sequencing platforms, automation integration levels, and accuracy and read-depth performance across service providers.
  • SERVICE DEPLOYMENT & LAB CAPACITY BENCHMARKS – helps you analyze number of operational sequencing labs by region, sample processing capacity, average project completion timelines, multi-site laboratory networks, and scalability in high-volume clinical and research environments.
  • OPERATIONAL COST & PRICING ANALYSIS – helps you assess average cost per genome or exome sequencing service, bioinformatics analysis charges, data storage and interpretation expenses, and cost reduction trends driven by workflow optimization and technology upgrades.
  • REGULATORY & DATA COMPLIANCE LANDSCAPE – helps you understand regional compliance with clinical laboratory standards, genetic data privacy regulations, quality accreditation requirements, and emerging regulatory trends influencing genomics service delivery.
  • ADOPTION & APPLICATION UTILIZATION INDEX – helps you track demand across clinical diagnostics, oncology, rare disease screening, pharmacogenomics, and research applications, along with enterprise versus academic adoption rates and repeat service utilization trends.
  • INVESTMENT & INNOVATION INTENSITY TRACKER – helps you measure R&D spending by leading genomics service providers, patent activity in sequencing and bioinformatics technologies, advancements in AI-driven genomic analysis, and competitive benchmarking based on service portfolio expansion and global reach.

Purchase Single User PDF of Genomics Services Market Report (20% Discount): https://www.snsinsider.com/checkout/2873

Genomics Services Market Report Scope

Report Attributes Details
Market Size in 2025  USD 7.94 Billion
Market Size by 2035  USD 25.18 Billion
CAGR  CAGR of 11.8% From 2026 to 2035
Base Year  2025
Forecast Period  2026-2035
Historical Data  2022-2024
Regional Analysis/Coverage North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America).

Table of Contents – Major Key Points

1. Introduction

2. Executive Summary

3. Market Overview

4. Statistical Insights & Trends Reporting

5. Genomics Services Market Segmental Analysis & Forecast, By Services Type

6. Genomics Services Market Segmental Analysis & Forecast, By Technology

7. Genomics Services Market Segmental Analysis & Forecast, By Application

8. Genomics Services Market Segmental Analysis & Forecast, By End User

9. Genomics Services Market Segmental Analysis & Forecast, By Region

10. Competitive Landscape

11. Analyst Recommendations

12. Assumptions

13. Disclaimer

14. Appendix

Access Complete Report Details of Genomics Services Market Analysis & Outlook: https://www.snsinsider.com/reports/genomics-services-market-2873

[For more information or need any customization research mail us at info@snsinsider.com]

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Us:
Rohan Jadhav - Principal Consultant
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: info@snsinsider.com

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. SingaporeOutlook.com takes no editorial responsibility for the same.

Related Articles